Dr. Reddy's Laboratories マネジメント
マネジメント 基準チェック /24
Dr. Reddy's Laboratoriesの CEO はErez Israeliで、 Apr2018年に任命され、 の在任期間は 6.58年です。 は、会社の株式の0.007%を直接所有しており、その価値は₹ 65.07M 。経営陣と取締役会の平均在任期間はそれぞれ6.6年と2.8年です。
主要情報
Erez Israeli
最高経営責任者
₹197.1m
報酬総額
CEO給与比率 | n/a |
CEO在任期間 | 6.6yrs |
CEOの所有権 | 0.007% |
経営陣の平均在職期間 | 6.6yrs |
取締役会の平均在任期間 | 2.8yrs |
経営陣の近況
Recent updates
Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?
Nov 23Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next
Nov 08Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price
Nov 01Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Oct 14If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Aug 19Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
Aug 01The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet
Jul 30Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly
Jul 12Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
Jun 23Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings
Jun 20Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00
May 26Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
May 10With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case
May 06There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding
Apr 18Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 02Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?
Jan 19Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E
Jan 01Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Oct 03Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
Jun 24Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year
Jun 10Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
May 27Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00
May 13Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Mar 06These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Dec 05CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹53b |
Jun 30 2024 | n/a | n/a | ₹56b |
Mar 31 2024 | ₹197m | n/a | ₹56b |
Dec 31 2023 | n/a | n/a | ₹52b |
Sep 30 2023 | n/a | n/a | ₹51b |
Jun 30 2023 | n/a | n/a | ₹47b |
Mar 31 2023 | ₹195m | n/a | ₹45b |
Dec 31 2022 | n/a | n/a | ₹36b |
Sep 30 2022 | n/a | n/a | ₹31b |
Jun 30 2022 | n/a | n/a | ₹30b |
Mar 31 2022 | ₹127m | n/a | ₹24b |
Dec 31 2021 | n/a | n/a | ₹26b |
Sep 30 2021 | n/a | n/a | ₹19b |
Jun 30 2021 | n/a | n/a | ₹17b |
Mar 31 2021 | ₹120m | n/a | ₹17b |
Dec 31 2020 | n/a | n/a | ₹21b |
Sep 30 2020 | n/a | n/a | ₹15b |
Jun 30 2020 | n/a | n/a | ₹19b |
Mar 31 2020 | ₹195m | ₹107m | ₹19b |
Dec 31 2019 | n/a | n/a | ₹16b |
Sep 30 2019 | n/a | n/a | ₹27b |
Jun 30 2019 | n/a | n/a | ₹21b |
Mar 31 2019 | ₹123m | n/a | ₹19b |
報酬と市場: Erezの 総報酬 ($USD 2.33M ) は、 Indian市場 ($USD 1.08M ) の同規模の企業の平均を上回っています。
報酬と収益: Erezの報酬は、過去 1 年間の会社の業績と一致しています。
CEO(最高経営責任者
Erez Israeli (56 yo)
6.6yrs
在職期間
₹197,090,000
報酬
Mr. Erez Israeli, MBA has been Chief Executive Officer of Dr. Reddy's Laboratories Limited since August 1, 2019 and has been its Member of the Management Council since April 02, 2018. Mr. Israeli served as...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Co-Chairman | 38.6yrs | ₹186.28m | 13.07% ₹ 130.7b | |
Chairman of the Board & Member of the Management Council | 31.8yrs | ₹116.17m | 13.61% ₹ 136.1b | |
CEO & Member of the Management Council | 6.6yrs | ₹197.09m | 0.0066% ₹ 65.5m | |
CFO & Member of the Management Council | less than a year | ₹48.82m | 0.0057% ₹ 56.7m | |
Global Head of Quality and Pharmacovigilance & Member of the Management Council | less than a year | ₹6.15m | データなし | |
CEO of API & Services & Member of Management Council | no data | ₹41.90m | 0.0027% ₹ 26.8m | |
CEO of Branded Markets - India & Emerging Countries and Member of Management Council | no data | ₹82.74m | 0.016% ₹ 157.3m | |
EVP, Head of Corporate Communications | 7.4yrs | ₹65.21m | 0.0063% ₹ 63.5m | |
Executive VP | 7.3yrs | ₹66.05m | データなし | |
CEO of European Generics & Member of Management Council | no data | ₹63.09m | データなし | |
Global Head of Integrated Product Development Organisation & Member of the Management Council | no data | ₹55.63m | 0.000020% ₹ 200.0k | |
Global Head – Biologics & Member of the Management Council | no data | ₹34.59m | データなし |
6.6yrs
平均在職期間
56yo
平均年齢
経験豊富な経営陣: DRREDDYの経営陣は経験豊富で経験豊富です(平均在職期間は6.6年)。
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Co-Chairman | 38.6yrs | ₹186.28m | 13.07% ₹ 130.7b | |
Chairman of the Board & Member of the Management Council | 31.8yrs | ₹116.17m | 13.61% ₹ 136.1b | |
Member of the Scientific Advisory Board | no data | ₹8.36m | データなし | |
Independent Director | 2.3yrs | ₹18.77m | データなし | |
Independent Director | 5.8yrs | ₹13.34m | データなし | |
Member of the Scientific Advisory Board | no data | データなし | データなし | |
Lead Independent Director | 6.1yrs | ₹17.10m | データなし | |
Independent Director | 2.8yrs | ₹14.18m | データなし | |
Independent Director | less than a year | ₹3.32m | データなし | |
Independent Director | 1.8yrs | ₹8.25m | データなし | |
Independent Director | 2.8yrs | ₹17.10m | データなし | |
Independent Director | 1.5yrs | ₹16.09m | データなし |
2.8yrs
平均在職期間
64yo
平均年齢
経験豊富なボード: DRREDDYの 取締役会 は 経験豊富 ではない ( 2.8年の平均在任期間) ため、新しい取締役会が必要であると考えられます。